This trial is looking to find better treatments for women with ovarian cancer that has come back. The trial is looking to find out if the drugs olaparib and cediranib are safe and work better than the standard chemotherapy drug paclitaxel. The drugs involved in this trial are: Paclitaxel – the known drug. This is a chemotherapy drug given …

The study aims to find out the answers to the following questions: Is one of these treatment approaches better than the other? Which treatment causes fewer side effects? Which treatment offers a better quality of life? Is it safe to use bevacizumab to treat women who are having surgery at the same time as chemotherapy? If you take …

The main purpose of conducting the trial is to: determine the safety of combining cediranib, a VEGF inhibitor, with paclitaxel a weekly chemotherapy regime find out how well the treatment works in terms of shrinking the cancer and preventing bowel obstruction. If the cancer responds to this treatment then after the course of paclitaxel…